6Schilling D, Haisch G, Sloot N, et al. Low seroprevalence of helieobacter pylori infection in patientswith stress ulcer bleeding - aprospetive evaluation of patients on a cardiosurgical intensive care unit[ J]. lntens Care Med,2000, 26:1832.
7Bareggi SR, GambaroV, ValentiM, et al. Absorption oforal lomoxicam in healthy volunteers using a granular formulation in comparison with standard tablets[ J ]. Drug Res, 1997,47:755.
9Jung R, MacLaren R. Proton -pump inhibitors for stress ulcer prophylaxis in critically ill patients[ J]. Ann Pharmaeother,2002,36 (12) : 1929.
10Leitner A, Zollner P. Visual documentation of the stability of intravenous solutions of omeprazole ( Losec ) and pantoprazole ( Pantoloc ) [ J ]. Wien Med Vfochenschr,2002,152 (21 - 22 ) :68.
1Thomas L,Culley EJ,Gladowski P,et al.Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization[].Journal of Managed Care Pharmacy.2010
